Mitochondrial dysfunction and calcium dysregulation in COQ8A -ataxia Purkinje neurons are rescued by CoQ10 treatment
Brain · 01.09.2023 · 146 (9) · 3836-3850
DOI: 10.1093/brain/awad099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 24.03.2023. Verfasst von Ioannis Manolaras und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Department of translational medecine and neurogenetics, 67404 Illkirch, Franc…. Hauptthemen laut MEDLINE: Cerebellar Ataxia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: frame of the E-Rare-3 network PREPARE, ANR, TREAT-ARCA.
Abstract (Originalsprache)
COQ8A-ataxia is a rare form of neurodegenerative disorder due to mutations in the COQ8A gene. The encoded mitochondrial protein is involved in the regulation of coenzyme Q10 biosynthesis. Previous studies on the constitutive Coq8a−/− mice indicated specific alterations of cerebellar Purkinje neurons involving altered electrophysiological function and dark cell degeneration. In the present manuscript, we extend our understanding of the contribution of Purkinje neuron dysfunction to the pathology. By generating a Purkinje-specific conditional COQ8A knockout, we demonstrate that loss of COQ8A in Purkinje neurons is the main cause of cerebellar ataxia. Furthermore, through in vivo and in vitro approaches, we show that COQ8A-depleted Purkinje neurons have abnormal dendritic arborizations, altered mitochondria function and intracellular calcium dysregulation. Furthermore, we demonstrate that oxidative phosphorylation, in particular Complex IV, is primarily altered at presymptomatic stages of the disease. Finally, the morphology of primary Purkinje neurons as well as the mitochondrial dysfunction and calcium dysregulation could be rescued by CoQ10 treatment, suggesting that CoQ10 could be a beneficial treatment for COQ8A-ataxia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Department of translational medecine and neurogenetics, 67404 Illkirch, France.
- Inserm, U1258, 67404 Illkirch, France.
- CNRS, UMR7104, 67404 Illkirch, France.
- Université de Strasbourg, 67000 Strasbourg, France.
- Institut Neuromyogène, Pathophysiology and genetics of the neuron and muscle, Inserm U1315, 69008 Lyon, France.
- CNRS, Université Claude Bernard Lyon I, UMR 5261, 69008 Lyon, France.
ORCID-Profile: Hélène Puccio
Förderung
- frame of the E-Rare-3 network PREPARE
- ANR
- TREAT-ARCA
- European Joint Programme on Rare Diseases
- AtaxiaXplorer
- French State fund
- Agence Nationale de la Recherche
- frame program Investissement d’Avenir
Zitieren
APA
Manolaras, I., Del Bondio, A., Griso, O., Reutenauer, L., Eisenmann, A., Habermann, B. H., & Puccio, H. (2023). Mitochondrial dysfunction and calcium dysregulation in COQ8A -ataxia Purkinje neurons are rescued by CoQ10 treatment. Brain, 146(9), 3836-3850. https://doi.org/10.1093/brain/awad099
Vancouver
Manolaras I, Del Bondio A, Griso O, Reutenauer L, Eisenmann A, Habermann BH, et al. Mitochondrial dysfunction and calcium dysregulation in COQ8A -ataxia Purkinje neurons are rescued by CoQ10 treatment. Brain. 2023;146(9):3836-3850. doi:10.1093/brain/awad099
BibTeX
@article{Manolaras2023,
author = {Manolaras, Ioannis and Del Bondio, Andrea and Griso, Olivier and Reutenauer, Laurence and Eisenmann, Aurélie and Habermann, Bianca H and Puccio, Hélène},
title = {Mitochondrial dysfunction and calcium dysregulation in COQ8A -ataxia Purkinje neurons are rescued by CoQ10 treatment},
journal = {Brain},
year = {2023},
volume = {146},
number = {9},
pages = {3836--3850},
doi = {10.1093/brain/awad099}
}
EUVIMED